Expectations are in place for a brisk pace of consolidation in the biotechnology space this year, and that could benefit an assortment of exchange traded funds, such as the ALPS Medical Breakthroughs ETF (SBIO). Like other ETFs addressing smaller biotech stocks, SBIO is coming off a trying 2021,...